glp 1 agonist and dementia Prevention of with GLP-1 Medications: Benefits & Insights Can one drug do it

Our reporters have teamed up with fitness experts to design dozens of routines

doi: 10.1128/CMR.05013-11 90 KimJYAhnMHSongHOChoiJHRyuJSMinDYet al

Cytokine signature associated with disease severity in chronic fatigue syndrome patients

Research found that supplementation with a range of Lactobacillus types improved kidney function, reduced inflammation and reversed leaky gut in female mice (x)

Injections do not have to pass through the digestive system like oral supplement, and thus the maximum absorption occurs and less time is consumed

it concerned highly purified eicosapentaenoic acid (EPA) (icosapent ethyl) which in a dose of 4 g/day demonstrated high efficacy in both primary prevention (in patients with diabetes and other risk factors) and secondary prevention in patients with ASCVD, reducing the primary endpoint of the study by 25% (HR = 0.75